Benzinga | Dec 1, 2020 08:45AM EST

Volition Launches Nu.Q Vet Cancer Screening Test In The US

AUSTIN, Texas, Dec. 1, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has announced the launch of its first product, the Nu.Q(tm) Vet Cancer Screening Test.